A ground-breaking prostate cancer treatment that aims to target tumours without as many side effects has showed promising ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about managing side effects following prostate cancer treatment. While treatment ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...
Hosted on MSN
Men with prostate cancer risk life-changing side effects because they can't access Cameron therapy
Thousands of men with prostate cancer risk life-changing side effects during treatment because they are not offered a therapy given to David Cameron. The former prime minister revealed last week he ...
PROSTOX test predicts urinary side effects in prostate cancer patients using microRNAs to assess genetic risk factors. The test identifies high-risk patients, who are 10 to 12 times more likely to ...
For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...
Steve, Jim, Andy and Tim Hastings found out they were battling the same disease within 6 months of one another ...
“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.
Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results